Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration
about
Towards Effective Photothermal/Photodynamic Treatment Using Plasmonic Gold Nanoparticles.Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined RoutingMultiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiencyEngineered nanomaterial uptake and tissue distribution: from cell to organismSize Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery.Toxicity of graphene-family nanoparticles: a general review of the origins and mechanismsEffect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitroEvaluation of uptake and distribution of gold nanoparticles in solid tumorsMetal Nanomaterial Toxicity Variations Within the Vascular SystemTranslocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experimentsEntering the era of nanoscience: time to be so small.Disposition of Intravenously or Orally Administered Silver Nanoparticles in Pregnant Rats and the Effect on the Biochemical Profile in UrineBiological mechanisms of gold nanoparticle radiosensitization.Role of Physicochemical Properties in Nanoparticle ToxicityRoadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization.Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation.Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: potential for targeting experimental brain tumors.In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokineticsQuantitative readout of optically encoded gold nanorods using an ordinary dark-field microscope.Aneuploidogenic effects and DNA oxidation induced in vitro by differently sized gold nanoparticlesIn vivo gold nanoparticle delivery of peptide vaccine induces anti-tumor immune response in prophylactic and therapeutic tumor models.Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars.Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat.Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration.Intrinsic therapeutic applications of noble metal nanoparticles: past, present and futureSize-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivoNanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.Acute hematologic, hepatologic, and nephrologic changes after intraperitoneal injections of 18 nm gold nanoparticles in hamsters.Sodium-22-radiolabeled silica nanoparticles as new radiotracer for biomedical applications: in vivo positron emission tomography imaging, biodistribution, and biocompatibilityAssessing the Intracellular Integrity of Phosphine-Stabilized Ultrasmall Cytotoxic Gold Nanoparticles Enabled by Fluorescence Labeling.Molecular imaging probes for multi-spectral optoacoustic tomography.Effects of naked gold nanoparticles on proinflammatory cytokines mRNA expression in rat liver and kidneyEvaluation of oxidative response and tissular damage in rat lungs exposed to silica-coated gold nanoparticles under static magnetic fields.Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy.A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles.Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle sizeIn vivo immune cell distribution of gold nanoparticles in naïve and tumor bearing mice.Gold nanoparticle mediated cancer immunotherapyIn vivo biodistribution of nanoparticles.Interactions of engineered nanoparticles with organs protected by internal biological barriers.
P2860
Q26741615-CBB3EA74-9B37-4224-932E-49405B98CB0FQ26746171-6FCA5CE2-2945-4644-A15A-3BC11621058CQ26827999-B18195F2-4C67-4E90-83D3-7CAF0F25BCBDQ26861914-600F48F7-37C7-48E2-B219-4979DC45AC1CQ27300748-B7F474DB-8BC9-4D7A-96DE-3C45927C5706Q28071613-D6BF45A9-992F-46A3-A563-61858836A941Q28385413-07B20035-5012-453D-A748-D7F46F0B90F8Q28390095-303F5713-260E-4811-B669-8DB193F8F48FQ28394244-1932C31B-81EC-4277-99B1-C914468AB49DQ28397256-7448A8EA-DDD2-4E44-8C6E-4D57CAD41F1FQ28681114-3E65EB01-0CA9-44AA-ABF8-9D2A32596D0EQ29248120-15297C0D-4F7B-4F33-9C92-4C3439E1237EQ29248405-C0F746D5-DA93-4CFF-8B61-61970BA6DC26Q29248830-A4B196F3-93A9-4BF3-8300-34085064CCF5Q30366774-6DE4D175-19A2-4746-A74C-5BB363C69266Q30379795-2FD4D44E-22AC-42E6-BA5B-E58311EA417BQ30407973-4A47DAE0-429E-46FA-B1DC-A64C2FA76EFAQ34463566-735D0CB7-A4EB-4B61-A5D6-B1C75395E754Q34801479-E48C8ABB-D54A-4331-81F7-145FD7D09B4FQ35173019-61D828C3-AC96-4CA0-85DC-73C81D209AD7Q35217609-BC8703FB-9950-4523-B534-DBB7F9B6099AQ35268464-41AB78E2-683C-4890-AB31-56ED0F1FCC4AQ35653525-F5D634A8-9BDF-40EB-BF95-72D8CEB4143BQ35703091-806CD4DB-9951-462B-B86F-9EA4692BF0CCQ35942437-BAB4CD33-B555-4F43-ABF3-7E51E6053368Q36017657-067569F8-7C5E-4954-B688-60586DF43E24Q36031889-9B6B6D97-0915-45F2-B786-25EE84ADC146Q36063720-36BD18E6-9591-4449-A457-5E77C3C59D15Q36160430-67237D51-8E3A-4EE8-9B5A-1041DC6BD0D3Q36196862-10C9D6DD-D4AB-4B2B-8030-3A3166B4F4A2Q36339518-95B4E654-ABB2-4F47-A6A9-D99DF63848D2Q36916144-2CD736F8-22BB-421B-9E2D-80E00441D6E2Q37003804-A45EFE1E-40A5-44C1-9FD7-79A8F6F56C5EQ37143010-9E7B9542-13C4-47D9-B8EF-9DB69260AB87Q37167472-ECB937F8-65BF-41DD-BEC8-BB37B80C4798Q37651373-5C95BEF1-6F78-4A20-908A-7427B3FCAC61Q37656558-A66871A7-F8CE-41B3-AC85-65A4B7A0F96CQ37666077-1A1918D1-6DED-4ABA-8701-FAB2F0E8BB13Q37906630-4D830ABE-8837-4A93-A5B4-BF689C16BC9EQ38055450-1882F9B8-BB77-4AA4-9E55-7687E4A944FB
P2860
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Particle size-dependent and su ...... ter intravenous administration
@ast
Particle size-dependent and su ...... ter intravenous administration
@en
Particle size-dependent and su ...... ter intravenous administration
@nl
type
label
Particle size-dependent and su ...... ter intravenous administration
@ast
Particle size-dependent and su ...... ter intravenous administration
@en
Particle size-dependent and su ...... ter intravenous administration
@nl
prefLabel
Particle size-dependent and su ...... ter intravenous administration
@ast
Particle size-dependent and su ...... ter intravenous administration
@en
Particle size-dependent and su ...... ter intravenous administration
@nl
P2093
P2860
P1476
Particle size-dependent and su ...... ter intravenous administration
@en
P2093
Alexander Wenk
Carsten Schleh
Günter Schmid
Jens Lipka
Manuela Semmler-Behnke
Martin Schäffler
Shinji Takenaka
Stephanie Hirn
Winfried Möller
P2860
P304
P356
10.1016/J.EJPB.2010.12.029
P407
P577
2010-12-31T00:00:00Z